Trademark: 90265717
Word
ISTARI
Status
Dead
Status Code
602
Status Date
Tuesday, September 13, 2022
Serial Number
90265717
Mark Type
4000
Filing Date
Tuesday, October 20, 2020
Published for Opposition
Tuesday, April 27, 2021
Abandoned Date
Tuesday, September 6, 2022

Trademark Owner History
Istari Oncology, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapy

Trademark Events
Sep 13, 2022
Abandonment Notice E-Mailed - Failure To Respond
Sep 13, 2022
Abandonment - Failure To Respond Or Late Response
Mar 2, 2022
Notification Of Non-Final Action E-Mailed
Mar 2, 2022
Non-Final Action E-Mailed
Mar 2, 2022
Su - Non-Final Action - Written
Mar 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2022
Statement Of Use Processing Complete
Feb 3, 2022
Use Amendment Filed
Mar 1, 2022
Sou Extension 1 Granted
Dec 22, 2021
Sou Extension 1 Filed
Feb 28, 2022
Case Assigned To Intent To Use Paralegal
Feb 3, 2022
Teas Statement Of Use Received
Feb 3, 2022
Notice Of Revival - E-Mailed
Feb 3, 2022
Extension Received With Teas Petition
Feb 3, 2022
Petition To Revive-Granted
Feb 3, 2022
Teas Petition To Revive Received
Jan 24, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 24, 2022
Abandonment - No Use Statement Filed
Jun 22, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 27, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2021
Published For Opposition
Apr 7, 2021
Notification Of Notice Of Publication E-Mailed
Mar 20, 2021
Approved For Pub - Principal Register
Mar 20, 2021
Assigned To Examiner
Dec 8, 2020
New Application Office Supplied Data Entered In Tram
Oct 23, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24